GlassScriptPhysician profile
Philip H Keyser
NPI 1003918780
$1,468.03
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $395 · 2021: $44.37 · 2022: $47.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $490.28 | 2019-2020 | |
| Abbott Laboratories | $245.09 | 2019-2022 | |
| Pfizer INC. | $138.73 | 2019-2020 | |
| Boston Scientific Corporation | $94.04 | 2019-2021 | |
| Amgen INC. | $69.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.52 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.45 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.79 | 2019-2020 | |
| Lundbeck LLC | $41.51 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.52 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $32.93 | 2019-2020 | |
| Amarin Pharma, INC. | $26.17 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.70 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.20 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $13.59 | 2019 | |
| Convatec INC. | $12.99 | 2019 | |
| Chiesi USA, INC. | $12.95 | 2019 | |
| Getinge USA Sales, LLC | $12.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Keyser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.